Earnings | Astec Lifesciences Ltd (NSE: ASTEC): Q4FY23 Results Out; Total Income fell 54% YoY.

Astec Lifesciences Ltd is a leading manufacturer of agrochemical products and active ingredients based in Mumbai, India. The company offers a range of products, including technical agrochemical active ingredients, bulk and formulation products, and intermediate products. Astec Lifesciences sells its products in India and exports them to approximately 24 countries, primarily in Europe, Japan, and the US. The company also undertakes custom synthesis projects for its clients in these regions. Astec Lifesciences is solely focused on business-to-business sales and has a strong commitment to innovation and sustainability in its operations.

• Astec Lifesciences Ltd reported Total Income for Q4 FY23 of ₹129 Crore down from ₹279 Crore year on year, a negative growth of 54%.
• Total Expenses for Q4 FY23 of ₹136 Crore down from ₹220 Crore year on year, a negative growth of 38%.
• Consolidated Net Profit of ₹-5 Crore, down 111% from ₹43 Crore in the same quarter of the previous year. 
• The Earnings per Share is ₹-2.54, down 111 % from ₹21.97 in the same quarter of the previous year.